Voices against the purchase are erupting in the Philippines, which has announced plans to purchase a vaccine for a novel coronavirus infection (Corona 19) developed by Chinese pharmaceutical company Sinobac.
On the 25th (local time), according to local media in the Philippines, including Raffler, members of the ruling and opposition lawmakers expressed their opposition to the government’s plan to purchase a synovac vaccine. Senate leader Juan Zubiri and opposition leader Franklin both issued opposition statements.
They were based on a Brazilian study that found that the synovac vaccine had only 50% of the corona 19 prevention effect.
Earlier, on the 23rd, the Butantang Research Center under the government of Sao Paulo Province, Brazil, analyzed the data from the phase 3 clinical trial of the Synovac vaccine and revealed that it showed more than 50% of the preventive effect. According to the analysis results, female and night lawmakers in the Philippines oppose the purchase of vaccines. Rep. Jubiri criticized that “the plan to secure a vaccine that has only 50% preventive effect is unacceptable,” and “it is funny that the possibility of contracting the corona19 virus is 50-50 even after vaccination.” Also, “It is important to supply the vaccine as soon as possible, but safety and efficacy should be prioritized over anything else.” “I doubt how to build public trust with a vaccine with 50% efficacy,” he said.
Earlier, the Philippines announced plans to purchase 25 million doses of vaccine from China‘s Sinovac by March next year. The Philippine government is not only in contact with Sinobag, but also with several pharmaceutical companies such as Pfizer and Moderna and AstraZeneca.
However, voices against the Philippine government’s purchase of a sinovac vaccine have erupted, raising concerns that the government’s purchase plan may be disrupted.
(Seoul = News 1)